Cartilage as a target of autoimmunity: A thin layer

Autoimmunity Reviews

Volumn 12, Issue 5, 2013, Pages 591-598

  Frisenda, Silvia ^a   Perricone, Carlo ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autoimmunity; Cartilage; Collagen; Relapsing polychondritis

Indexed keywords

COLLAGEN TYPE 2; COLLAGEN TYPE 4; COLLAGEN TYPE 6; GAMMA INTERFERON; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2; LINK PROTEIN; MATRILIN 3;

ARTICULAR CARTILAGE; AUTOIMMUNITY; BEHCET DISEASE; CARTILAGE CELL; COLLAGEN DISEASE; GRANULOMATOSIS; HUMAN; INFLAMMATION; MACROPHAGE; OSTEOARTHRITIS; OSTEOCLAST; PLASMA CELL; POLYCHONDRITIS; RELAPSE; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIOCYTE; TH0 CELL; TH1 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; COLLAGEN; DISEASE MODELS, ANIMAL; ELASTIC CARTILAGE; HUMANS; HYALINE CARTILAGE; MENISCI, TIBIAL;

EID: 84875251601     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.10.003     Document Type: Review

References (82)

1. Cremer M.A., Rosloniec E.F., Kang A.H. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998, 76:275-288.
2. Stuart J.M., Watson W.C., Kang A.H. Collagen autoimmunity and arthritis. FASEB J 1988, 2:2950-2956.
3. Roughley P.J. Articular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage. Arthritis Res 2001, 3:342-347.
4. Steffan C., Timpl R. Antigenicity of collagen and its application in the serologic investigation of rheumatoid arthritis sera. Arch Allergy Appl Immunol 1963, 22:333-334.
5. Andriopoulos N.A., Mestecky J., Miller E.J., Bradley E.L. Antibodies to native and denatured collagen in sera of patients with rheumatoid arthritis. Arthritis Rheum 1976, 19:613-617.
6. Reginato A.M., Olsen B.R. The role of structural genes in the pathogenesis of osteoarthritic disorders. Arthritis Res 2002, 4:337-345.
7. Becerra J., Andrades J.A., Guerado E., Zamora-Navas P., López-Puertas J.M., Reddi A.H. Articular cartilage: structure and regeneration. Tissue Eng Part B Rev 2010, 16:617-627.
8. Hedbom E., Antonsson P., Hjerpe A., Aeschlimann D., Paulsson M., Rosa-Pimentel E., et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992, 267:6132-6136.
9. Christensen A.F., Lindegaard H., Hørslev-Petersen K., Hetland M.L., Ejbjerg B., Stengaard-Pedersen K., et al. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis. J Rheumatol 2011, 38:1563-1568.
10. Young-Gyu C., Mi-La C., So-Youn M., Ho-Youn K. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 2007, 7:65-70.
11. Holmdahl R. Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol 1998, 10:710-717.
12. Griffiths M.M., Remmers E.F. Genetic analysis of collagen induced arthritis in rats: a polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci. Immunol Rev 2001, 184:172-183.
13. Bäcklund J., Treschow A., Bockermann R., Holm B., Holm L., Issazadeh-Navikas S., et al. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 2002, 32:3776-3784.
14. Croxford A.M., Crombie D., McNaughton D., Holmdahl R., Nandakumar K.S., Rowley M.J. Specific antibody protection of the extracellular cartilage matrix against collagen antibody-induced damage. Arthritis Rheum 2010, 62:3374-3384.
15. Carter N.A., Rosser E.C., Mauri C. IL-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of Tr1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther 2012, 14:R32.
16. Blom A.M., Nandakumar K.S., Holmdahl R. C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice. Ann Rheum Dis 2009, 68:136-142.
17. Brand D.D., Kang A.H., Rosloniec E.F. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003, 25:3-18.
18. Eyre D. Collagen of articular cartilage. Arthritis Res 2002, 4:30-35.
19. Carlsen S., Lu S., Holmdahl R. Arthritis induced with minor cartilage proteins. Methods Mol Med 2007, 136:225-242.
20. van Bilsen J.H., van Dongen H., Lard L.R., van der Voort E.I., Elferink D.G., Bakker A.M., et al. Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. Proc Natl Acad Sci U S A 2004, 101:17180-17185.
21. Posey K.L., Hecht J.T. The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets 2008, 9:869-877.
22. Carlsen S., Nandakumar K.S., Bäcklund J., Holmberg J., Hultqvist M., Vestberg M., et al. Cartilage oligomeric matrix protein induction of chronic arthritis in mice. Arthritis Rheum 2008, 58:2000-2011.
23. Di Paola P., Cuzzocrea S. Predictivity and sensitivity of animal models of arthritis. Autoimmun Rev 2008, 8:73-75.
24. Saxne T., Heinegård D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992, 31:583-591.
25. Hansson A.S., Heinegard D., Piette J.C., Burkhardt H., Holmdahl R. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum 2001, 44:2402-2412.
26. Rédini F. Proteoglycans: complex diversity in structure and functions. Methods Mol Biol 2012, 836:8-9.
27. Glant T.T., Mikecz K. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis. Methods Mol Med 2004, 102:313-338.
28. Boldizsar F., Tarjanyi O., Nemeth P., Mikecz K., Glant T.T. Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. Int Immunol 2009, 21:511-522.
29. Shibata S., Sasaki T., Harpel P., Fillit H. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes. Clin Immunol Immunopathol 1994, 70:114-123.
30. Renaudineau Y., Révélen R., Dueymes M., Levy Y., Youinou P. Autoantibodies to heparan sulfate proteoglycans. Autoimmun Rev 2002, 1:305-312.
31. Leheita O., Abed Elrazek N.Y., Younes S., Mahmoud A.Z. Lymphocytes subsets in osteoarthritis versus rheumatoid arthritis. Egypt J Immunol 2005, 12:113-124.
32. Nishioka K. Autoimmune response in cartilage-delivered peptides in a patient with osteoarthritis. Arthritis Res Ther 2004, 6:6-7.
33. Sakata M., Masuko-Hongo K., Nakamura H., Onuma H., Tsuruha J.I., Aoki H., et al. Osteoarthritic articular chondrocytes stimulate autologous T cell responses in vitro. Clin Exp Rheumatol 2003, 21:704-710.
34. Wang Q., Rozelle A., Lepus C., Scanzello C., Song J., Larsen D., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
35. Gordon D.A. Hastings DE clinical features of rheumatoid arthritis. Rheumatology 2003, 765-780. Mosby, Edinburgh. 3rd edn. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblat, M.H. Weisman (Eds.).
36. Harris E.D.Jr Pathogenesis of rheumatoid arthritis. Textbook of Rheumatology 1985, 886-903. WB Saunders, Philadelphia, Penn. second ed. W.N. Kelley, E.D. Harris, R. Ruddy, C.B. Sledge (Eds.).
37. Steffan C., Timpl R. Antigenicity of collagen and its application in the serologic investigation of rheumatoid arthritis sera. Arch Allergy Appl Immunol 1963, 22:333-349.
38. Andriopoulos N.A., Mestecky J., Miller E.J., Bradley E.L. Antibodies to native and denatured collagen in sera of patients with rheumatoid arthritis. Arthritis Rheum 1976, 19:613-617.
39. Stuart J.M., Huffstutter E.H., Townes A.S., Kang A.H. Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum 1983, 26:832-840.
40. Lafeber F.P., Van der Laan W.H. Progression of joint damage despite control of inflammation in rheumatoid arthritis: a role for cartilage damage driven synovial fibroblast activity. Ann Rheum Dis 2012, 71:793-795.
41. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34:1218-1227.
42. Rufai A., Ralphs J.R., Benjamin M. Structure and histopathology of the insertional region of the human Achilles tendon. J Orthop Res 1995, 13:585-593.
43. Benjamin M., Rufai A., Ralphs J.R. The mechanism of formation of bony spurs (enthesophytes) in the achilles tendon. Arthritis Rheum 2000, 43:576-583.
44. Benjamin M., Ralphs J.R. Biology of fibrocartilage cells. Int Rev Cytol 2004, 233:1-45.
45. Benjamin M., McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol 2009, 649:57-70.
46. Poole A.R. The histopathology of ankylosing spondylitis: are there unifying hypotheses?. Am J Med Sci 1998, 316:228-233.
47. François R.J., Gardner D.L., Degrave E.J., Bywaters E.G. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum 2000, 43:2011-2024.
48. Jaksch-Wartenhorst R. Polychondropathia. Wien Arch F Inn Med 1923, 6:93-100.
49. Lahmer T., Treiber M., von Werder A., Foerger F., Knopf A., Heemann U., et al. Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev 2010, 9:540-546.
50. Letko E., ZaWrakis P., Baltatzis S., Voudouri A., Livir-Rallatos C., Foster C.S. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 2002, 31:384-395.
51. Paroli M., Priori R., Spinucci G., Abicca I., Valesini G. Case report: uveitis with retinal occlusive vasculitis and sensorineural hypoacusia as first symptoms of relapsing polychondritis. Clin Exp Rheumatol 2012, 30(1 Suppl 70):S101-S103. [Jan-Feb].
52. McAdam L.P., O'Hanlan M.A., Bluestone R., Pearson C.M. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976, 55:193-215.
53. Michet C.J., McKenna C.H., Luthra H.S., O'Fallon W.M. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986, 104:74-78.
54. Kong K.O., Vasoo S., Tay N.S., Chng H.H. Relapsing polychondritis-an Oriental case series. Singapore Med J 2003, 44:197-200.
55. Priori R., Conti F., Pittoni V., Valesini G. Relapsing polychondritis: a syndrome rather than a distinct clinical entity?. Clin Exp Rheumatol 1997, 15:334-335.
56. Trentham D.E. Relapsing polychondritis. Ann Intern Med 1998, 129:114-122.
57. Kindblom L.G., Dalen P., Edmar G., Kjellbo H. Relapsing polychondritis. A clinical, pathologic-anatomic and histochemical study of 2 cases. Acta Pathol Microbiol Scand 1977, 85:656-664.
58. Foidart J.M., Abe S., Martin G.R., Zizic T.M., Barnett E.V., Lawley T.J., et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978, 299:1203-1207.
59. Meyer O., Cyna J., Dryll A., Cywiner-Golenzer C., Wassef M., Ryckewaert A. Relapsing polychondritis-pathogenic role of anti-native collagen type II antibodies. A case report with immunological and pathological studies. J Rheumatol 1981, 8:820-824.
60. Yang C.L., Brinckmann J., Rui H.F., Vehring K.H., Lehmann H., Kekow J., et al. Autoantibodies to cartilage collagens in relapsing polychondritis. Arch Dermatol Res 1993, 285:245-249.
61. Alsalameh S., Mollenhauer J., Scheuplein F., Stoss H., Kalden J.R., Burkhardt H., et al. Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis. J Rheumatol 1993, 20:1419-1424.
62. Paulsson M., Piecha D., Segat D., et al. The matrilins: a growing family of A-domain-containing proteins. Biochem Soc Trans 1999, 27:824-826.
63. Paulsson M., Heinegard D. Radioimmunoassay of the 148-kilodalton cartilage protein. Distribution of the protein among bovine tissues. Biochem J 1982, 207:207-213.
64. Hansson A.S., Holmdahl R. Cartilage-specific autoimmunity in animal models and clinical aspects in patients-focus on relapsing polychondritis. Arthritis Res 2002, 4:296-301.
65. Buckner J.H., Wu J.J., Reife R.A., Terato K., Eyre D.R. Autoreactivity against matrilin-1 in a patient with relapsing polychondritis. Arthritis Rheum 2000, 43:939-943.
66. Bergfeld W.F. Relapsing polychondritis with positive direct immunofluorescence. Arch Dermatol 1978, 114:127.
67. Chang-Miller A., Okamura M., Torres V.E., Michet C.J., Wagoner R.D., Donadio J.V., et al. Renal involvement in relapsing polychondritis. Medicine (Baltimore) 1987, 66:202-217.
68. Hansson A.S., Johannesson M., Svensson L., Nandakumar K.S., Heinegård D., Holmdahl R. Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease. Am J Pathol 2004, 164:959-966.
69. MicHet C.J. Vasculitis a and relapsing polycondritis. Rheum Dis Clin North Am 1990, 16:441-444.
70. Foidart J.M., Abe S., Martin G.R., Zizic T.M., Barnett E.V., Lawley T.J., et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978, 299:1203-1207.
71. Ng C.S., Hogan P., McKenzie S., Gibbs H., Strutton G., Wong R. Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome complicated by aneurysmal aortitis. J Clin Rheumatol 2007, 13:221-223.
72. Firestein G.S., Gruber H.E., Weisman M.H., Zvaifler N.J., Barber J., O'Duffy J.D. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome: five patients with features of relapsing polychondritis and Behçet's disease. Am J Med 1985, 79:65-72.
73. Hidalgo-Tenorio C., Sabio-Sánchez J.M., Linares P.J., Salmerón L.M., Ros-Die E., Jiménez-Alonso J. Magic syndrome and true aortic aneurysm. Clin Rheumatol 2008, 27:115-117.
74. Goueffic Y., Pistorius M.A., Heymann M.F., Chaillou P., Patra P. Association of aneurysmal and occlusive lesions in Behcet's disease. Ann Vasc Surg 2005, 19:276-279.
75. Barretto S.N., Oliveira G.H., Michet C.J., Nyman M.A., Edwards W.D., Kullo I.J. Multiple cardiovascular complications in a patient with relapsing polychondritis. Mayo Clin Proc 2002, 77:971-974.
76. Michet C.J., McKenna C.H., Luthra H.S., O'Fallon W.M. Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med 1986, 104:74-78.
77. Gertner E. Severe recurrent neurological disease in the MAGIC syndrome. J Rheumatol 2004, 31:1018-1019.
78. Shahram F., Zarandy M.M., Ibrahim A., Ziaie N., Saidi M., Nabaei B., et al. Nasal mucosal involvement in Behçet disease: a study of its incidence and characteristics in 400 patients. Ear Nose Throat J 2010, 89:30-33.
79. Wierzbicka M., Gaweqcki W., Pastusiak T., Szyfter W. Subglottic stenosis in Wegener's granulomatosis-a diagnostic and therapeutic problem. Otolaryngol Pol 2010, 64:15-19.
80. Valesini G., Priori R., Conti F. Saddle nose. N Engl J Med 1995, 333:525-526.
81. Small P., Black M., Davidman M., de Champlain M.L., Kapusta M.A., Kreisman H. Wegener's granulomatosis and relapsing polychondritis: a case report. J Rheumatol 1980, 7:915-918.
82. Kittisupamongkol W., Kulwichit W. Relapsing polychondritis or ANCA-negative Wegener's granulomatosis?. Med J Aust 2007, 187:478-479.